Page last updated: 2024-10-26

stallimycin and Experimental Neoplasms

stallimycin has been researched along with Experimental Neoplasms in 2 studies

Research Excerpts

ExcerptRelevanceReference
"Suramin is a synthetic anticancer agent that works, in part, by blocking the binding of growth factors to their receptors."1.30Inhibition of growth factor mitogenicity and growth of tumor cell xenografts by a sulfonated distamycin A derivative. ( Calabresi, P; Chen, TM; Chu, MY; Epstein, MH; Finch, PW; Friedman, S; Lipsky, MH; Maciag, T; Yee, LK, 1997)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Finch, PW1
Yee, LK1
Chu, MY1
Chen, TM1
Lipsky, MH1
Maciag, T1
Friedman, S1
Epstein, MH1
Calabresi, P1
Pezzoni, G1
Grandi, M1
Biasoli, G1
Capolongo, L1
Ballinari, D1
Giuliani, FC1
Barbieri, B1
Pastori, A1
Pesenti, E1
Mongelli, N1

Other Studies

2 other studies available for stallimycin and Experimental Neoplasms

ArticleYear
Inhibition of growth factor mitogenicity and growth of tumor cell xenografts by a sulfonated distamycin A derivative.
    Pharmacology, 1997, Volume: 55, Issue:6

    Topics: 3T3 Cells; Animals; Antineoplastic Agents; Cell Line, Transformed; Cells, Cultured; Cytokines; Dista

1997
Biological profile of FCE 24517, a novel benzoyl mustard analogue of distamycin A.
    British journal of cancer, 1991, Volume: 64, Issue:6

    Topics: Animals; Antineoplastic Agents; Cell Division; Cell Survival; Distamycins; In Vitro Techniques; Mice

1991